Biotechnology firm Akadeum Life Sciences announced the closing of a $20 million financing round that will enable the company to advance its CGT product suite. Michigan Capital Network led the investment alongside contributions from Arboretum Ventures, NYBC Ventures, and other investors. The funding follows the launch of the firm’s GMP-compliant product launch and will be…

Companies that address individuals’ nonmedical social needs such as food insecurity, transportation, isolation and loneliness, are carving out a place in the healthcare market. Many of these companies work with health plans to serve hard-to-reach, vulnerable populations, and, as these startups grow, there are opportunities to combine capabilities to extend their reach. READ MORE

Rio Rancho, New Mexico-based NTx Bio will establish a biomanufacturing facility in Plano, creating more than 170 new jobs and more than $31 million in capital investment, Gov. Greg Abbott announced. A Texas Enterprise Fund (TEF) grant of nearly $1.5 million has been extended to NTx Bio, also known as Nature’s Toolbox Inc. Founded in…

SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ — CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering. The company’s strong growth has been fueled by its innovative Syn-One Test® that uses skin biopsy tissue to detect…

LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, an Emmy award-winning sports broadcaster, producer and director. Storm, who was diagnosed with ductal carcinoma in situ (DCIS), also known at stage 0 breast cancer, in early 2024, is…

LAGUNA HILLS, Calif., Jan. 16, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation for its DCISionRT® test. READ MORE

TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ — GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced the company has completed a $37 million first close of a Series D financing round. READ MORE

RIO RANCHO, N.M., January 09, 2025–(BUSINESS WIRE)–Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial availability of NTxscribe®, a benchtop, continuous flow RNA in vitro transcription (IVT) and purification system that brings cost effective and scalable RNA manufacturing to the market. READ MORE

BOSTON, Oct. 1, 2024 – Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). PlaqueIQ is the first FDA-cleared non-invasive software that can objectively quantify and classify plaque morphology based on ground-truth histology, the gold…

GT Medical Technologies, maker of the GammaTile bioresorbable collagen tile, announced that it secured a $35 million venture loan facility. Within the loan facility, Horizon Technology Finance Corporation, an affiliate of Monroe Capital, funded an initial $15 million. In addition to Horizon, the company has backing from a number of top-tier investors. That list includes MVM…

RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company building next generation platforms to manufacture RNA and protein, announced today that it has raised $47.5M in Series B financing. Led by RA Capital Management, the investment will fuel the advancement of the company’s biomanufacturing platforms, NTxscribe® and NTxpress®. Acceleration of these technology foundations…

MINNEAPOLIS–(BUSINESS WIRE)–Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation, today announced a majority growth investment from TT Capital Partners (TTCP). The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces…

MINNEAPOLIS–(BUSINESS WIRE)–Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation, today announced a majority growth investment from TT Capital Partners (TTCP). The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces…

BOSTON, June 22, 2022 /PRNewswire/ — Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round.  The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex Ventures,…

LAGUNA HILLS, Calif., March 22, 2022 /PRNewswire/– Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that it has closed a $20 million funding round led by Evidity Health Capital and joined by existing and new investors. Alejandro Sanchez, Managing Director of Evidity Health Capital, will be…

Phoenix, AZ – BlueStone portfolio company, GT Medical Technologies, Inc. received the Innovator of the Year Award in the Small Company category (companies with less than $50M in revenue) at the Governor’s Celebration of Innovation, an awards ceremony put on by the Arizona Technology Council and the Arizona Commerce Authority. READ MORE

Tempe, AZ – GT Medical Technologies, Inc. today announced it is presenting clinical data in two oral presentations on the company’s breakthrough GammaTile® Therapy for patients with brain tumors at the 2021 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting. The presenting authors, Dr. David Brachman, co-founder and CTO at GT Medical Technologies and Dr. Mehee Choi, director…

Tucson, AZ – Pyx Health, a tech-enabled services company providing health plans and their members an innovative, scalable solution that effectively addresses the nation’s critical loneliness epidemic, announced today that it has received a strategic investment from Rallyday Partners, a Denver-based private equity investment firm. The funding will enable Pyx Health to enhance and scale its service…

Tucson, AZ – Pyx Health, a tech-enabled services company providing health plans and their members an innovative, scalable solution that effectively addresses A white paper reveals that Banner University Health Plans’ use of a novel interactive platform-plus-support center with members after discharge from emergency room or inpatient care resulted in a substantial reduction in subsequent inpatient costs…

Tempe, AZ – GT Medical Technologies Inc. had a very productive year in 2020 when it came to publishing about key aspects of GammaTile® Therapy. This included 4 publications in peer-reviewed journals, 9 abstracts presented at a variety of industry conferences,  and 1 white paper detailing access to care for radiation therapy in the US.  READ MORE

GT Medical Technologies Inc. has raised $16 million to expand its commercialization of a targeted radiation therapy for patients with brain tumors. Led by London-based private equity firm MVM Partners LLP, this latest round follows a $10 million raise in early 2019, bringing its total raise to $29 million. Existing investors San Francisco-based MedTech Venture…

Tempe, Arizona – BlueStone portfolio company, GT Medical Technologies, today announced new data from a clinical study of the company’s GammaTile® Therapy in patients with large brain metastases, or tumors that spread to the brain from cancer in another part of the body. Approximately 150,000 – 200,000 people are diagnosed with brain metastases each year in the…

Tempe, Arizona – BlueStone portfolio company, GT Medical Technologies, was named to Medical Design & Outsourcing  20 Medical Device Startups You Need to Know List. READ MORE

Tempe, Arizona –The MedTech world is about more than just building better medical devices. It’s also about technologies that, when applied with ingenuity, can help accelerate the entire biopharma enterprise. This means leveraging CRISPR-based gene-editing techniques to make it cheaper and easier to translate ideas into therapies, or to build more-sensitive and shelf-stable diagnostic tests—or even to make…

Tucson, Arizona –BlueStone Venture Partners announces the acquisition of one of its portfolio companies, Paradigm Diagnostics, Inc (“Paradigm”) by Exact Sciences Corporation (“Exact Sciences”). On March 3, Exact Sciences of Madison, Wisconsin, announced the completion of its acquisition of Paradigm and Viomics, cancer diagnostics companies based in Phoenix, Arizona.  Paradigm enables Exact Sciences to expand its…

Tempe, Arizona –GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for GammaTile® Therapy. Patients with newly diagnosed malignant brain tumors are now eligible to receive the FDA-cleared surgically targeted radiation therapy (STaRT) ​We are…

Chandler, Arizona –The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards. Approximately 400,000 Americans are newly diagnosed with some type of brain tumor each year. For decades, clinicians have sought better treatments for these…

Scottsdale, Arizona & Tempe, Arizona – HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with all types of recurrent brain tumors.…

Tempe, Arizona – GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced the presentation of clinical data from a prospective study of GammaTile® Therapy in patients with previously irradiated intracranial neoplasms (brain tumors) at the American Brachytherapy Society (ABS) 2019 Annual Meeting in Miami. These data reinforce the…

Tempe, Arizona – GT Medical Technologies has created a new way to target brain tumors like the type that took the late Senator John McCain’s life. GammaTile technology, invented and developed in Arizona, consists of four tiles implanted in a patient. These tiles contain dosages of radiation that targets glioblastomas. We’ll get more from Dr. David…

Tempe, Arizona –Listen to The Health Technology podcast from UCSF Rosenman Institute to hear GT Medical Technologies, Inc. CEO Matt Likens share how GammaTile Therapy challenges the current standard of care for patients with recurrent brain tumors by improving quality of life and delaying time to recurrence for all tumor pathologies (gliomas, meningiomas, metastases, etc.). LISTEN HERE

Tempe, Arizona & San Diego, California – BlueStone portfolio company GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that Peter Nakaji, M.D., GT MedTech’s co-founder and director of the Neurosurgery Residency Program at Barrow Neurological Institute in Phoenix, has been selected by the American Association of Neurological…

Tempe, Arizona & Minneapolis, Minnesota –  University of Minnesota Health (M Health) is the first health system in the United States to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT™) that is designed to delay tumor regrowth for patients with brain tumors.…

Minneapolis, Minnesota –  It sounds like science fiction, but doctors at University of Minnesota Health are the first in the country to offer an implantable form of radiation to target brain cancer. The implant is called GammaTile Therapy and Linda Tinega was the first patient in Minnesota to receive it.  “Each tile, has four, radioactive seeds on…